Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
BA.5.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
BA.5.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CR.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CR.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CR.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CR.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CR.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.2.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-21921China
BQ.1.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16811.6China
BQ.1.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used